top of page

High on-treatment platelet
reactivity (HTPR) to aspirin and clopidogrel

Many patients on standard dual antiplatelet therapy exhibit high on-treatment platelet reactivity (HTPR) , a risk factor for post-procedural thrombotic events.

Multiplate helps clinicians detect inadequate platelet inhibition early.

Platelet function testing can identify patients who may benefit from tailored antiplatelet therapy
general-knowledge-icon-vector.jpg

RESOURCE TYPE

LinkedIn Post

LinkedIn post introducing this study and inviting discussion.

Read LinkedIn Post
general-knowledge-icon-vector.jpg

RESOURCE TYPE

Customer Brief

Customer brief summarising key findings

View Customer Brief
general-knowledge-icon-vector.jpg

RESOURCE TYPE

Journal Article

Multiplate® testing supports better decision-making and potentially improved outcomes in vascular interventions. Read it here

Read Journal Article

Want to discuss  a research project?

Our team is here to help.

bottom of page